Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

118.98 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Dexcom Inc

< Previous 1 2 3 Next >
DexCom Comments on SVB Relationship
From DexCom, Inc.
Via Business Wire
Dexcom Announces Upcoming Conference Presentations
From DexCom, Inc.
Via Business Wire
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
From Dexcom, Inc.
Via Business Wire
Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From DexCom, Inc.
Via Business Wire
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expanding Platform to Integrate Market-Leading CGM Data
Via Investor Brand Network
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
From DexCom, Inc.
Via Business Wire
Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Insulet Has Potential To Gain More Than Analysts Are Forecasting
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range. 
Via MarketBeat
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
From DexCom, Inc.
Via Business Wire
Dexcom Appoints Teri Lawver as Chief Commercial Officer
From DexCom, Inc.
Via Business Wire
Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
Can FDA Approval Bolster DexCom, Inc.?
Dexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value). 
Via MarketBeat
Exposures Product Safety
Kaival Brands ($KAVL) and KMS gear up for anticipated revenue growth by hiring former Swisher International VP of Sales
Via AB Newswire
Topics Economy
Exposures Interest Rates
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
From DexCom, Inc.
Via Business Wire
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
CapitalGainsReport Sector Spotlight: Wearable Health (DXCM, WHSI, IRTC, BTCY)
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care
From DexCom, Inc.
Via Business Wire
Dexcom Reports Third Quarter 2022 Financial Results
From DexCom, Inc.
Via Business Wire
Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes
From DexCom, Inc.
Via Business Wire
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
From DexCom, Inc.
Via Business Wire
Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Dexcom Announces Upcoming Conference Presentations
From DexCom, Inc.
Via Business Wire
DexCom Promotes Jake Leach to Chief Operating Officer
From DexCom, Inc.
Via Business Wire
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Dexcom Reports Second Quarter 2022 Financial Results
From DexCom, Inc.
Via Business Wire
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
From Dexcom, Inc.
Via Business Wire
Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association
From DexCom, Inc.
Via Business Wire
Dexcom Issues Statement on Recent Market Speculation
From DexCom, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.